radiopharmaceutical therapy

You have access
Rethinking Dosimetry: A European Perspective
Johannes Tran-Gia, Francesco Cicone, Michel Koole, Francesco Giammarile, Jonathan Gear, Emmanuel Deshayes, Pablo Minguez Gabiña, Marta Cremonesi, Jonathan Wadsley, Peter Bernhardt, Manuel Bardiès, Silvano Gnesin, Mattias Sandström, Ulrike Garske-Román, Mona-Elisabeth R. Revheim, Frederik A. Verburg, Mark Konijnenberg, Bernd Joachim Krause, Michael Lassmann and Caroline Stokke

Journal of Nuclear Medicine May 22, 2025, jnumed.124.269378; DOI: https://doi.org/10.2967/jnumed.124.269378
You have access
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy
Fabio Turco, Silke Gillessen, Ken Herrmann, Gaetano Paone and Aurelius Omlin

Journal of Nuclear Medicine May 1, 2025, 66 (5) 665-672; DOI: https://doi.org/10.2967/jnumed.124.267730
Open Access
Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning
Carlos Vinícius Gomes, Yizhou Chen, Isabel Rauscher, Song Xue, Andrei Gafita, Jiaxi Hu, Robert Seifert, Lorenzo Mercolli, Julia Brosch-Lenz, Jimin Hong, Marc Ryhiner, Sibylle Ziegler, Ali Afshar-Oromieh, Axel Rominger, Matthias Eiber, Thiago Viana Miranda Lima and Kuangyu Shi

Journal of Nuclear Medicine May 1, 2025, 66 (5) 778-784; DOI: https://doi.org/10.2967/jnumed.124.268175
You have access
A Phase I/II Study of [¹⁷⁷Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol
Sara Harsini, Maryam Soleimani, Don Wilson, Carlos Uribe, Heather Saprunoff, Ingrid Bloise and Francois Benard

Journal of Nuclear Medicine April 30, 2025, jnumed.124.269064; DOI: https://doi.org/10.2967/jnumed.124.269064
You have access
Multicycle Dosimetric Behavior and Dose–Effect Relationships in [¹⁷⁷Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Gunjan Kayal, Molly E. Roseland, Chang Wang, Kellen Fitzpatrick, David Mirando, Krithika Suresh, Ka Kit Wong and Yuni K. Dewaraja

Journal of Nuclear Medicine April 24, 2025, jnumed.124.269389; DOI: https://doi.org/10.2967/jnumed.124.269389
You have access
Evidence-Based Clinical Protocols to Monitor Efficacy of [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M. Unterrainer, Nicolas De Leiris, Marcus Unterrainer, Astrid Delker, Linus Hempel, Zachary Ells, Sophie C. Kunte, Josef Zahner, Adrien Holzgreve, Mathias J. Zacherl, Gabriel T. Sheikh, Jozefina Casuscelli, Julien Leenhardt, Kenneth J. Pienta, Emmanuelle Jacquet, Mathieu Laramas, Jerome Long, Marine Faure, Ghislaine Reboulet, Channing J. Paller, Alexis Mercier, Lilja B. Solnes, Kevin Kiraz, Harun Ilhan, Andrei Gafita and Loïc Djaileb

Journal of Nuclear Medicine April 24, 2025, jnumed.124.269431; DOI: https://doi.org/10.2967/jnumed.124.269431
You have access
Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Louise Kostos, James P. Buteau, Grace Kong, Ben Tran, Mohammad B. Haskali, Michael Fahey, Megan Crumbaker, Louise Emmett, Michael S. Hofman and Arun A. Azad

Journal of Nuclear Medicine April 1, 2025, 66 (4) 572-578; DOI: https://doi.org/10.2967/jnumed.124.269252
You have access
Comparison of [⁶⁸Ga]Ga-Fibroblast Activation Protein Inhibitor–04 and [¹⁸F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical Therapy
Rongxi Wang, Jiarou Wang, Jialin Xiang, Huimin Sui, Linlin Li, Chenhao Jia, Xingtong Peng, Xiaoyuan Chen, Zhaohui Zhu and Jingjing Zhang

Journal of Nuclear Medicine April 1, 2025, 66 (4) 585-591; DOI: https://doi.org/10.2967/jnumed.124.268258
Open Access
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
Peter J. Gawne, Helen E. Bryant, Steven G. DuBois, Sally L. George, Juliet Gray, Leona Knox, Kyle B. Matchett, Connie Peet, Katherine A. Vallis, Hugh J. Wallace, Simon Wan and Mark N. Gaze

Journal of Nuclear Medicine April 1, 2025, 66 (4) 490-496; DOI: https://doi.org/10.2967/jnumed.124.269121
You have access
^99mTc-MIP-1404 SPECT/CT Companion Diagnostic for ¹⁷⁷Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Thorsten Derlin, Liam Widjaja, Nina Natascha Harke, Christoph Czerner, Desiree Weiberg, Tobias L. Ross and Frank M. Bengel

Journal of Nuclear Medicine March 1, 2025, 66 (3) 366-372; DOI: https://doi.org/10.2967/jnumed.124.269319

Main menu

User menu

Search

radiopharmaceutical therapy

Pages